Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IMMUNOTRAP

Financiado

Cerrado

Diagnosis test for immuno oncology therapies.

Cancers exhibit a large heterogeneity in terms of genetic mutations, so they respond differently to the same drugs. This is why oncology is rapidly drifting towards treatments with new disrupting personalised inmuno-oncology thera... ver más

29/02/2020

IMPETUX OPTICS SL.

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

IMPETUX OPTICS SL. Comercio al por mayor y al por menor.distribucion comercial.importacion y exportacion.prestacion de servicios.investigacion,desarrollo e inn...

TRL 4-5 | 198K€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-02-29

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

IMPETUX OPTICS SL.

50.00K€ | Lider

INMUNOTEK

808.88K€ | Participante

Proyectos interesantes

ImmunoCode

Medical Technol...

Data Science

2M€ Cerrado

PID2020-118529RB-I00

Medical Technol...

Data Science

218K€ Cerrado

OncoSeq

Medical Technol...

Data Science

150K€ Cerrado

PID2020-116393RB-I00

Medical Technol...

Data Science

257K€ Cerrado

BioProbe-PIT

Medical Technol...

Nanotechnology

150K€ Cerrado

CPP2021-008390

Medical Technol...

Cancer Research

225K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 6 meses Fecha Inicio: 2019-08-02
Fecha Fin: 2020-02-29

Líder del proyecto

IMPETUX OPTICS SL. Comercio al por mayor y al por menor.distribucion comercial.importacion y exportacion.prestacion de servicios.investigacion,desarrollo e inn...

TRL 4-5 | 198K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancers exhibit a large heterogeneity in terms of genetic mutations, so they respond differently to the same drugs. This is why oncology is rapidly drifting towards treatments with new disrupting personalised inmuno-oncology therapies based on adoptive T-cell transfer (ACT). These therapies aim at selecting the most efficient T cells against tumors and transferring them back to the patient. This kind of Immunoassays are generally carried out with endpoint measurements like Surface Plasmon Resonance or Flow Cytometry. However, these techniques do not allow assessing the binding process between the immune and the target cell, which represents a fundamental step of the recognition phase where large efforts against cancer focus. IMPETUX has developed a solution to address this unmet need. The characterization of this affinity will be achieved through the measurement of the interaction force between them with IMMUNOTRAP: a platform for cell screening based on IMPETUX‘s optical tweezers. This technology uses a highly-focused laser light to mechanically interact with the sample without physical contact. The recent 2018 Nobel Prize in Physics was awarded to the intellectual father of this technique for his ground-breaking invention in the 1980s. However, it was not until few years ago that forces could start being measured on non-homogeneous samples, such as cells, thanks to the technology developed by IMPETUX. The IMMUNOTRAP has the potential to become the workhorse in the screening of the best performance receptors for their use in immunotherapies and offers IMPETUX the opportunity to address a high-growth potential market: the pharmaceutical industry and clinical diagnosis. It represents, therefore, a key opportunity to boost the company’s growth. Thus, the objectives of the present innovation project is precisely to confirm the potential of the proposal to create value and to identify the most suitable marketing and commercial routes for a successful market entry.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores